Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Generics to Be Listed for 6 Major Products with Sales of Over \10 Bil.
March 26, 2007
- 152 Generics Approved for the Same Indications as Original Drugs
March 26, 2007
- Generics Should Use the Same Excipients as Original Drugs: Dr Kawashima of Santen
March 26, 2007
- NEW PRODUCT
March 26, 2007
- Kyorin to License at Least 1 Compound Per Year at Late Stage
March 26, 2007
- Korosho Proposes 7 Measures to Promote Innovation
March 26, 2007
- Japan-China Medical Cooperation Initiatives to Symbolize Fraternity: Mr Niwa
March 26, 2007
- R&D NEWS IN BRIEF
March 26, 2007
- FPMAJ to Propose NHI Pricing System Reform Plan in August
March 26, 2007
- Lactoferrin Improves Dyslipidemia: Lion
March 19, 2007
- Seretide Reduces Risk of Death in COPD: GSK
March 19, 2007
- Japan, China Agree to Cooperate in Developing Anticancer Drugs
March 19, 2007
- SymBio Completes Enrollment into PI Trial of Bendamustine
March 19, 2007
- R&D NEWS IN BRIEF
March 19, 2007
- Mr Matsumoto Likely to Serve 4th Term as JACDS President
March 19, 2007
- Korosho to Issue GL on Ads on Medical Services
March 19, 2007
- Private Univ. Hospitals, Wholesalers Show Mutual Approach
March 19, 2007
- Appropriate Use of Antibiotics Recommended in Treating Otitis Media
March 19, 2007
- Novo Nordisk Aims at Top Position in 3 Fields: Mr Eilersen
March 19, 2007
- MEDICAL FACILITIES&NURSING CARE NEWS IN BRIEF
March 19, 2007
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…